CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key Findings of the Study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. Asia-Pacific IVF Services Market, By End User

3.2.1. Market size and forecast
3.2.2. Market volume and forecast
3.2.3. Fertility clinics

3.2.3.1. Market size and forecast

3.2.4. Hospitals

3.2.4.1. Market size and forecast

3.2.5. Surgical centers

3.2.5.1. Market size and forecast

3.2.6. Clinical research institutes

3.2.6.1. Market size and forecast

3.3. Asia-Pacific IVF Services Market, by Cycle Type

3.3.1. Market size and forecast
3.3.2. Market volume and forecast
3.3.3. Fresh IVF cycles (non-donor)

3.3.3.1. Market size and forecast

3.3.4. Thawed IVF cycles (non-donor)

3.3.4.1. Market size and forecast

3.3.5. Donor egg IVF cycles

3.3.5.1. Market size and forecast

3.4. Asia-Pacific IVF services market, by country

3.4.1. Market size and forecast
3.4.2. Market volume and forecast

3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. Delayed pregnancies in women
3.5.1.2. Increase in global infertility rates
3.5.1.3. Increase in gamete donations
3.5.1.4. Increase in disposable income
3.5.1.5. Increase in IVF success rates

3.5.2. Restraints

3.5.2.1. Complications associated with IVF treatment
3.5.2.2. Low awareness level

3.5.3. Opportunities

3.5.3.1. Fertility tourism
3.5.3.2. Growth opportunities in the Asia-Pacific region
3.5.3.3. Increase in number of fertility clinics

3.5.4. Impact analyses

CHAPTER 4: INDIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

4.1. Overview

4.1.1. Market size and forecast

4.2. Fertility Center in India
4.3. India IVF Services Market, By End User

4.3.1. Market size and forecast
4.3.2. Market volume and forecast
4.3.3. Fertility clinics
4.3.4. Hospitals
4.3.5. Surgical centers
4.3.6. Clinical research institutes

4.4. India IVF Services Market, By Cycle Type

4.4.1. Market size and forecast
4.4.2. Market volume and forecast
4.4.3. Fresh IVF cycles (non-donor)
4.4.4. Thawed IVF cycles (non-donor)
4.4.5. Donor egg IVF cycles

4.5. Market Dynamics

4.5.1. Driving factors
4.5.2. Restraining factors

4.6. Regulatory Issues, Legislations and Authorities
4.7. Insurance Reimbursement Scenario
4.8. Company Profiles

4.8.1. Bourn Hall Fertility Center

4.8.1.1. Company overview

4.8.2. Southend Fertility and IVF

4.8.2.1. Company overview

4.8.3. Morpheus Life Sciences Pvt. Ltd.

4.8.3.1. Company overview

4.8.4. Bloom Fertility Center

4.8.4.1. Company overview

4.8.5. Bloom Fertility and Healthcare

4.8.5.1. Company overview

4.8.6. Manipal Fertility

4.8.6.1. Company overview

4.8.7. Cloudnine Fertility

4.8.7.1. Company overview

4.8.8. Chennai Fertility Center

4.8.8.1. Company overview

CHAPTER 5: CHINA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

5.1. Overview

5.1.1. Market size and forecast

5.2. China IVF Services Market, By End User

5.2.1. Market size and forecast
5.2.2. Market volume and forecast
5.2.3. Fertility clinics
5.2.4. Hospitals
5.2.5. Surgical centers
5.2.6. Clinical research institutes

5.3. China IVF Services Market, By Cycle Type

5.3.1. Market size and forecast
5.3.2. Market volume and forecast
5.3.3. Fresh IVF cycles (non-donor)
5.3.4. Thawed IVF cycles (non-donor)
5.3.5. Donor egg IVF cycles

5.4. Market Dynamics

5.4.1. Driving factors
5.4.2. Restraining Factors

5.5. Regulatory Issues, Legislations and Authorities
5.6. Insurance Reimbursement Scenario
5.7. Company Profiles

5.7.1. Shanghai Ji Ai Genetics & IVF Institute

5.7.1.1. Company overview

5.7.2. Shanghai United Family Hospital

5.7.2.1. Company overview

CHAPTER 6: JAPAN IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

6.1. Overview

6.1.1. Market size and forecast

6.2. Japan IVF Services Market, By End User

6.2.1. Market size and forecast
6.2.2. Market volume and forecast
6.2.3. Fertility clinics
6.2.4. Hospitals
6.2.5. Surgical centers
6.2.6. Clinical research institutes

6.3. Japan IVF Services Market, By Cycle Type

6.3.1. Market size and forecast
6.3.2. Market volume and forecast
6.3.3. Fresh IVF cycles (non-donor)
6.3.4. Thawed IVF cycles (non-donor)
6.3.5. Donor egg IVF cycles

6.4. Market Dynamics

6.4.1. Driving factors
6.4.2. Restraining Factors

6.5. Regulatory Issues, Legislations and Authorities
6.6. Insurance Reimbursement Scenario
6.7. Company Profiles

6.7.1. IVF NAMBA Clinic

6.7.1.1. Company overview

6.7.2. Sanno Hospital

6.7.2.1. Company overview

6.7.3. Oak Medical Group/Oak Clinic

6.7.3.1. Company overview

CHAPTER 7: AUSTRALIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

7.1. Overview

7.1.1. Market size and forecast

7.2. Fertility Center in Australia
7.3. Australia IVF Services Market, By End User

7.3.1. Market size and forecast
7.3.2. Market volume and forecast
7.3.3. Fertility clinics
7.3.4. Hospitals
7.3.5. Surgical centers
7.3.6. Clinical research institutes

7.4. Australia IVF Services Market, By Cycle Type

7.4.1. Market size and forecast
7.4.2. Market volume and forecast
7.4.3. Fresh IVF cycles (non-donor)
7.4.4. Thawed IVF cycles (non-donor)
7.4.5. Donor egg IVF cycles

7.5. Market Dynamics

7.5.1. Driving factors
7.5.2. Restraining Factors

7.6. Regulatory Issues, Legislations and Authorities
7.7. Insurance Reimbursement Scenario
7.8. Company Profiles

7.8.1. Virtus Health

7.8.1.1. Company overview

7.8.2. Monash IVF Wesley Hospital Auchenflower

7.8.2.1. Company overview

7.8.3. Fertility First

7.8.3.1. Company overview

7.8.4. Flinders Reproductive Medicine Pty Ltd

7.8.4.1. Company overview

CHAPTER 8: NEW ZEALAND IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

8.1. Overview

8.1.1. Market size and forecast

8.2. New Zealand IVF Services Market, By End User

8.2.1. Market size and forecast
8.2.2. Market volume and forecast
8.2.3. Fertility clinics
8.2.4. Hospitals
8.2.5. Surgical centers
8.2.6. Clinical research institutes

8.3. New Zealand IVF Services Market, By Cycle Type

8.3.1. Market size and forecast
8.3.2. Market volume and forecast
8.3.3. Fresh IVF cycles (non-donor)
8.3.4. Thawed IVF cycles (non-donor)
8.3.5. Donor egg IVF cycles

8.4. Market Dynamics

8.4.1. Driving factors
8.4.2. Restraining Factors

8.5. Regulatory Issues, Legislations and Authorities
8.6. Insurance Reimbursement Scenario
8.7. Company Profiles

8.7.1. Fertility Associates

8.7.1.1. Company overview

8.7.2. Genea Oxford Fertility Limited

8.7.2.1. Company overview

8.7.3. Repromed

8.7.3.1. Company overview

CHAPTER 9: SOUTH KOREA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

9.1. Overview

9.1.1. Market size and forecast

9.2. Fertility Center in South Korea
9.3. South Korea IVF Services Market, By End User

9.3.1. Market size and forecast
9.3.2. Market volume and forecast
9.3.3. Fertility clinics
9.3.4. Hospitals
9.3.5. Surgical centers
9.3.6. Clinical research institutes

9.4. South Korea IVF Services Market, By Cycle Type

9.4.1. Market size and forecast
9.4.2. Market volume and forecast
9.4.3. Fresh IVF cycles (non-donor)
9.4.4. Thawed IVF cycles (non-donor)
9.4.5. Donor egg IVF cycles

9.5. Market Dynamics

9.5.1. Driving factors
9.5.2. Restraining Factors

9.6. Regulatory Issues, Legislations and Authorities
9.7. Insurance Reimbursement Scenario
9.8. Company Profiles

9.8.1. CHA Fertility Center

9.8.1.1. Company overview

9.8.2. Maria Fertility Hospital

9.8.2.1. Company overview

CHAPTER 10: THAILAND IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

10.1. Overview

10.1.1. Market size and forecast

10.2. Thailand IVF Services Market, By End User

10.2.1. Market size and forecast
10.2.2. Market volume and forecast
10.2.3. Fertility clinics
10.2.4. Hospitals
10.2.5. Surgical centers
10.2.6. Clinical research institutes

10.3. Thailand IVF Services Market, By Cycle Type

10.3.1. Market size and forecast
10.3.2. Market volume and forecast
10.3.3. Fresh IVF cycles (non-donor)
10.3.4. Thawed IVF cycles (non-donor)
10.3.5. Donor egg IVF cycles

10.4. Market Dynamics

10.4.1. Driving factors
10.4.2. Restraining Factors

10.5. Regulatory Issues, Legislations and Authorities
10.6. Insurance Reimbursement Scenario
10.7. Company Profiles

10.7.1. SAFE Fertility Center

10.7.1.1. Company overview

10.7.2. Bangkok IVF Center (Bangkok Hospital)

10.7.2.1. Company overview

10.7.3. Bangkok IVF center

10.7.3.1. Company overview

CHAPTER 11: SINGAPORE IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

11.1. Overview

11.1.1. Market size and forecast

11.2. Singapore IVF Services Market, By End User

11.2.1. Market size and forecast
11.2.2. Market volume and forecast
11.2.3. Fertility clinics
11.2.4. Hospitals
11.2.5. Surgical centers
11.2.6. Clinical research institutes

11.3. Singapore IVF Services Market, By Cycle Type

11.3.1. Market size and forecast
11.3.2. Market volume and forecast
11.3.3. Fresh IVF cycles (non-donor)
11.3.4. Thawed IVF cycles (non-donor)
11.3.5. Donor egg IVF cycles

11.4. Market Dynamics

11.4.1. Driving factors
11.4.2. Restraining factors

11.5. Regulatory Issues, Legislations and Authorities
11.6. Insurance Reimbursement Scenario
11.7. Company Profiles

11.7.1. National University Hospital

11.7.1.1. Company overview

11.7.2. IHH Healthcare Berhad

11.7.2.1. Company overview

11.7.3. Thomson Medical Pte. Ltd.

11.7.3.1. Company overview

11.7.4. Raffles Medical Group

11.7.4.1. Company overview

CHAPTER 12: MALAYSIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

12.1. Overview

12.1.1. Market size and forecast

12.2. Malaysia IVF Services Market, By End User

12.2.1. Market size and forecast
12.2.2. Market volume and forecast
12.2.3. Fertility clinics
12.2.4. Hospitals
12.2.5. Surgical centers
12.2.6. Clinical research institutes

12.3. Malaysia IVF Services Market, By Cycle Type

12.3.1. Market size and forecast
12.3.2. Market volume and forecast
12.3.3. Fresh IVF cycles (non-donor)
12.3.4. Thawed IVF cycles (non-donor)
12.3.5. Donor egg IVF cycles

12.4. Market Dynamics

12.4.1. Driving factors
12.4.2. Restraining factors

12.5. Regulatory Issues, Legislations and Authorities
12.6. Insurance Reimbursement Scenario
12.7. Company Profiles

12.7.1. Damai Service Hospital

12.7.1.1. Company overview

12.7.2. TMC Fertility Centre

12.7.2.1. Company overview

12.7.3. KL Fertility & Gynecology Centre

12.7.3.1. Company overview

CHAPTER 13: INDONESIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

13.1. Overview

13.1.1. Market size and forecast

13.2. Indonesia IVF Services Market, By End User

13.2.1. Market size and forecast
13.2.2. Market volume and forecast
13.2.3. Fertility clinics
13.2.4. Hospitals
13.2.5. Surgical centers
13.2.6. Clinical research institutes

13.3. Indonesia IVF Services Market, By Cycle Type

13.3.1. Market size and forecast
13.3.2. Market volume and forecast
13.3.3. Fresh IVF cycles (non-donor)
13.3.4. Thawed IVF cycles (non-donor)
13.3.5. Donor egg IVF cycles

13.4. Market Dynamics

13.4.1. Driving factors
13.4.2. Restraining factors

13.5. Regulatory Issues, Legislations and Authorities
13.6. Insurance Reimbursement Scenario
13.7. Company Profiles

13.7.1. Morula IVF

13.7.1.1. Company overview

13.7.2. Lotus Fertility Clinic

13.7.2.1. Company overview

13.7.3. RSUP Dr. Hasan Sadikin Bandung

13.7.3.1. Company overview

CHAPTER 14: PHILIPPINES IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

14.1. Overview

14.1.1. Market size and forecast

14.2. Philippines IVF Services Market, By End User

14.2.1. Market size and forecast
14.2.2. Market volume and forecast
14.2.3. Fertility clinics
14.2.4. Hospitals
14.2.5. Surgical centers
14.2.6. Clinical research institutes

14.3. Philippines IVF Services Market, By Cycle Type

14.3.1. Market size and forecast
14.3.2. Market volume and forecast
14.3.3. Fresh IVF cycles (non-donor)
14.3.4. Thawed IVF cycles (non-donor)
14.3.5. Donor egg IVF cycles

14.4. Market Dynamics

14.4.1. Driving factors
14.4.2. Restraining factors

14.5. Regulatory Issues, Legislations and Authorities
14.6. Insurance Reimbursement Scenario
14.7. Company Profiles

14.7.1. Victory A.R.T. Laboratory Phils., Inc.

14.7.1.1. Company overview

14.7.2. Center for Advanced Reproductive Medicine and Infertility

14.7.2.1. Company overview

CHAPTER 15: VIETNAM IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

15.1. Overview

15.1.1. Market size and forecast

15.2. Vietnam IVF Services Market, By End User

15.2.1. Market size and forecast
15.2.2. Market volume and forecast
15.2.3. Fertility clinics
15.2.4. Hospitals
15.2.5. Surgical centers
15.2.6. Clinical research institutes

15.3. Vietnam IVF Services Market, By Cycle Type

15.3.1. Market size and forecast
15.3.2. Market volume and forecast
15.3.3. Fresh IVF cycles (non-donor)
15.3.4. Thawed IVF cycles (non-donor)
15.3.5. Donor egg IVF cycles

15.4. Market Dynamics

15.4.1. Driving factors
15.4.2. Restraining factors

15.5. Regulatory Issues, Legislations and Authorities
15.6. Insurance Reimbursement Scenario
15.7. Company Profiles

15.7.1. IVF Van Hanh

15.7.1.1. Company overview

15.7.2. Tu Du Hospital

15.7.2.1. Company overview

CHAPTER 16: MYANMAR IVF SERVICES MARKET (REVENUE AND NUMBER OF CYCLES)

16.1. Overview
16.2. Market size and forecast
16.3. Myanmar IVF Services Market, By End User

16.3.1. Market size and forecast
16.3.2. Market volume and forecast
16.3.3. Fertility clinics
16.3.4. Hospitals
16.3.5. Surgical centers
16.3.6. Clinical research institutes

16.4. Myanmar IVF Services Market, By Cycle Type

16.4.1. Market size and forecast
16.4.2. Market volume and forecast
16.4.3. Fresh IVF cycles (non-donor)
16.4.4. Thawed IVF cycles (non-donor)

16.5. Market Dynamics

16.5.1. Driving factors
16.5.2. Restraining factors

16.6. Regulatory issues, legislations, and authorities
16.7. Insurance Reimbursement Scenario
16.8. Company Profiles

16.8.1. Bahosi Fertility Centre

16.8.1.1. Company overview

16.8.2. Bumrungrad International Hospital

16.8.2.1. Company overview

16.8.3. Superior A.R.T Myanmar

16.8.3.1. Company overview

CHAPTER 17: REST OF ASIA-PACIFIC IVF SERVICES MARKET (REVENUE AND NUMBER OF CYCLES)

17.1. Overview

17.1.1. Market size and forecast

17.2. Rest of Asia-Pacific IVF Services Market, By End User

17.2.1. Market size and forecast
17.2.2. Market volume and forecast
17.2.3. Fertility clinics
17.2.4. Hospitals
17.2.5. Surgical centers
17.2.6. Clinical research institutes

17.3. Rest of Asia-Pacific IVF Services Market, By Cycle Type

17.3.1. Market size and forecast
17.3.2. Market volume and forecast
17.3.3. Fresh IVF cycles (non-donor)
17.3.4. Thawed IVF cycles (non-donor)
17.3.5. Donor egg IVF cycles

17.4. Market Dynamics

17.4.1. Driving factors
17.4.2. Restraining factors

17.5. Regulatory issues, legislations, and authorities
17.6. Insurance Reimbursement Scenario
17.7. Company Profiles